ICON9 Trial

An international phase III randomised study to evaluate the efficacy of maintenance cediranib and olaparib combination therapy or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

Existing samples:

  • Malignant tumour of ovary

Contact Information

Email:
ctc.icon9@ucl.ac.uk
Address:

Cancer Research UK & UCL Cancer Trials Centre
90 Tottenham Court Road
London
London
W1T 4TJ
UK

Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A